Calmate Sells for $650,000 at Keeneland
The 4-year-old daughter of Vekoma brought the top price at the Keeneland November Breeding Stock Sale, with Jody Huckabay acting as agent.
Updated on Nov. 5, 2026 in Equestrian
Calmate, a 4-year-old daughter of Vekoma consigned by Hunter Valley Farm as Hip 771, sold for $650,000 to Jody Huckabay as agent during the Keeneland November Breeding Stock Sale. She was sold in foal to Nyquist, the fourth-ranked stallion in North America.
Why it matters
The sale marks a significant return for the partnership Natalma, which bought Calmate for $190,000 at the prior year's Keeneland November sale. Her winning half sister Litmus Test recently gained attention with a 2025 Los Alamitos Futurity (G2) victory.
Calmate sold for $650,000, up from the $190,000 the partnership Natalma paid for her at the 2025 Keeneland November sale. Litmus Test won the 2025 Los Alamitos Futurity by 1 1/4 lengths for trainer Bob Baffert and his ownership partners.
The players
Jody Huckabay
Jody Huckabay acted as agent for the buyer in the $650,000 purchase of Calmate at the Keeneland November Breeding Stock Sale.
Nyquist
Nyquist is a stallion ranked fourth in North America, and Calmate was sold in foal to him.
Bob Baffert
Bob Baffert is a Hall of Fame thoroughbred trainer whose ownership partners campaigned Litmus Test to victory in the 2025 Los Alamitos Futurity.
The details
Calmate was consigned by Hunter Valley Farm as Hip 771 and sold in foal to Nyquist during the Keeneland November Breeding Stock Sale. Her half sister Litmus Test won at first asking at Del Mar before finishing fourth in the Del Mar Futurity (G1), third in the Breeders' Futurity (G1), and fourth in the Breeders' Cup Juvenile (G1).
Timeline
Calmate was purchased by Natalma for $190,000 at the Keeneland November sale of the prior year.
Litmus Test won the 2025 Los Alamitos Futurity (G2) that year.
In June, Litmus Test finished fifth in the Affirmed Stakes at Santa Anita Park.
Calmate sold for $650,000 at the Keeneland November Breeding Stock Sale on November 5, 2026.
Roadmap
Calmate's $650,000 price at the Keeneland November Breeding Stock Sale reflects the premium the market places on pedigree connections to graded-stakes winners. Her increase from the $190,000 paid the prior year shows how quickly broodmare value can rise when a family's racing results strengthen.
For breeders and owners, Calmate's price shows the premium placed on mares with graded-stakes pedigrees at the Keeneland November sale. Buyers and sellers in the Kentucky market can use this result to gauge current values for broodmares tied to winning families.
The takeaway
Pedigree connections to graded-stakes winners can sharply raise a broodmare's value within a single year. Breeders weighing purchases should track the racing results of a mare's relatives as closely as her own record.
Further reading
For more on the state's breeding and racing scene, see Equestrian coverage across Kentucky.
Source note: This article includes information reported by Blood Horse Interactive.
